These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Extensive epidermal necrosis due to terlipressin. Yefet E; Gershovich M; Farber E; Soboh S Isr Med Assoc J; 2011 Mar; 13(3):180-1. PubMed ID: 21608341 [No Abstract] [Full Text] [Related]
5. Terlipressin-induced skin necrosis and rhabdomyolysis. Zimmer V; Lammert F Am J Med Sci; 2010 Dec; 340(6):506. PubMed ID: 20818227 [No Abstract] [Full Text] [Related]
6. Cutaneous necrosis secondary to terlipressin therapy. A rare but serious side effect. Case report and literature review. Iglesias Julián E; Badía Aranda E; Bernad Cabredo B; Corrales Cruz D; Romero Arauzo MJ Rev Esp Enferm Dig; 2017 May; 109(5):380-382. PubMed ID: 28112958 [TBL] [Abstract][Full Text] [Related]
7. Ischaemic complications of Glypressin in liver disease: a case series. Donnellan F; Cullen G; Hegarty JE; McCormick PA Br J Clin Pharmacol; 2007 Oct; 64(4):550-2. PubMed ID: 17880357 [TBL] [Abstract][Full Text] [Related]
8. Linear IgA bullous dermatosis due to vancomycin and cutaneous necrosis due to terlipressin in the same patient. Castellanos-González M; Marzal-Alfaro MB; Díaz-Sánchez A; Martos MG Indian J Dermatol Venereol Leprol; 2016; 82(6):723-726. PubMed ID: 27643543 [No Abstract] [Full Text] [Related]
9. Two observations raising questions about risk factors of cutaneous necrosis induced by terlipressin (Glypressin). Mégarbané H; Barete S; Khosrotehrani K; Izzedine H; Moguelet P; Chosidow O; Frances C; Aractingi S Dermatology; 2009; 218(4):334-7. PubMed ID: 19155616 [TBL] [Abstract][Full Text] [Related]
13. Worsening of cerebral hyperemia by the administration of terlipressin in acute liver failure with severe encephalopathy. Shawcross DL; Davies NA; Mookerjee RP; Hayes PC; Williams R; Lee A; Jalan R Hepatology; 2004 Feb; 39(2):471-5. PubMed ID: 14768000 [TBL] [Abstract][Full Text] [Related]
14. Treatment of active gastroesophageal variceal bleeding with terlipressin or hemostatic balloon in patients with cirrhosis. A randomized controlled trial. García-Compeán D; Blanc P; Bories JM; Michel J; Desprez D; Pageaux GP; David XR; Larrey D; Michel H Arch Med Res; 1997; 28(2):241-5. PubMed ID: 9204616 [TBL] [Abstract][Full Text] [Related]
15. Toxic rhabdomyolysis induced by terlipressin infusion in a uraemic patient suffering from AA-type amyloidosis. Rolla D; Cannella G; Ravetti JL Nephron; 1999; 83(2):167-8. PubMed ID: 10516498 [No Abstract] [Full Text] [Related]